(PharmaNewsWire.Com, March 02, 2017 ) According to Publisher, the Global Allergy Diagnostics Market is accounted for $2.70 billion in 2015 and is expected to reach $6.29 billion by 2022 growing at a CAGR of 12.8% during the forecast period. Factors such as rising healthcare expenses, growing environmental pollution, increasing geriatric population and huge financial burden of allergic diseases are fueling the market growth. However, stringent regulations and huge capital investments are hampering the market.
The assay kits segment commanded the largest share of the global market and is also anticipated to grow at the fastest CAGR due to the growing count of allergic diseases. North America dominated the global market owing to the increasing aging population and rising pollution due to urbanization in the region. However, the Asia Pacific is expected to grow at a faster pace due to the presence of largely untapped market.
Some of the key players in allergy diagnostics market include Siemens AG, Danaher Corporation, Omega Diagnostics Group PLC, HYCOR Biomedical, HOB Biotech Group Co., Ltd, Hitachi Chemical Diagnostics, Inc., Stallergenes Greer, BioMérieux, Thermo Fisher Scientific, Inc., Lincoln Diagnostics, Inc., Allercheck Inc., Bio-Diagnostics Ltd., SmartPractice Denmark ApS, ERBA Mannheim Group, Terumo Medical Corporation and Diagenics Ltd.
Allergens Covered: - Seasonal Allergens - Inhaled Allergens o Dust Allergy - Drug Allergens - Anaphylaxis/Contact Allergens o Plant Origin o Insect Sting Allergy - Food Allergens - Other Allergens
Products Covered: - Consumables - Assay Kits - Instruments o Luminometers o Immunoassay Analyzers o Elisa Analyzers o Other Instruments
Diagnostic Test Types Covered: - In Vitro Tests o Blood Test - In Vivo Tests o Skin Test o Patch Test - Elimination Diet - Other Diagnostic Test Types
End Users Covered: - Hospitals o Allergists / Immunologists o Physicians - Academic Research Institutes - Diagnostic Laboratories o Pathology Laboratories - Other End Users
Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt
What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements
Company Profiling 11.1 Siemens AG 11.2 Danaher Corporation 11.3 Omega Diagnostics Group PLC 11.4 HYCOR Biomedical 11.5 HOB Biotech Group Co., Ltd 11.6 Hitachi Chemical Diagnostics, Inc. 11.7 Stallergenes Greer 11.8 BioMérieux 11.9 Thermo Fisher Scientific, Inc. 11.10 Lincoln Diagnostics, Inc. 11.11 Allercheck Inc. 11.12 Bio-Diagnostics Ltd. 11.13 SmartPractice Denmark ApS 11.14 ERBA Mannheim Group 11.15 Terumo Medical Corporation 11.16 Diagenics Ltd.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
